SEC Form D · filed May 13, 2016
DalCor Pharmaceuticals US, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Rody M. Yared · Montreal, Quebec, CanadaDirectorRobert Mcneil · San Mateo, CAExec · Director · PromoterLouise M. Proulx · Montreal, Quebec, CanadaExecD. M. Dixon · Montreal, Quebec, CanadaExec · DirectorMark M. Smith · Montreal, Quebec, CanadaDirectorLaurence M. Rulleau · Montreal, Quebec, CanadaDirectorThomas M. Birch · Montreal, Quebec, CanadaDirectorJeffrey Krol · Winnetka, ILDirectorJeffrey E. Bennis · Denver, CODirectorBryan E. Roberts · Palo Alto, CADirectorJay K. Alexander · Denver, COExec · Director · PromoterRichard W. Stone · Denver, CODirectorCamille D. Samuels · Palo Alto, CAExecPeter Mcdonnell · Winnetka, ILExec · DirectorDidier M. Leconte · Montreal, Quebec, CanadaDirectorLarry A. Lance · Denver, CODirectorPaul E. Andrews · Denver, COExec · Director · PromoterRobert P. Kocher · Palo Alto, CAExecThomas Scott · Winnetka, ILExec · DirectorKane Street Long GP LLC · New York, NYDirectorKane Street Capital Management LLC · New York, NYDirectorMichael C. Blue · Ann Arbor, MIDirectorDidier M. Leconte · Montreal, Quebec, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗